Protocol No.
163189 (LYL845-101)
Principal Investigator
Hyngstrom, John
Phase
I
Age Group
Adult
ClinicalTrials.Gov
NCT05573035 (Click to jump to clinicaltrials.gov)
Title
Phase I Study to Assess the Safety and Efficacy of LYL845 in Adults with Relapsed and/or Refractory Metastatic or Locally Advanced Melanoma and Selected Solid Tumor Malignancies
Objective
Applicable Disease Sites
Melanoma
Participating Institutions
Huntsman Cancer Institute
Status
Open
Clinical trials search powered by Forte Research Systems